Clinical Roundup Study: Keytruda reduced the risk of distant metastasis or death versus placebo as adjuvant treatment in melanoma indication September 25, 2020Vol.46 No.36
Clinical Roundup Keytruda + chemotherapy demonstrated superior OS/PFS versus chemotherapy in GEJ cancer indication September 25, 2020Vol.46 No.36
Clinical Roundup Phase III CheckMate -9ER trial: Opdivo + Cabometyx demonstrates significant survival benefits in advanced RCC September 25, 2020Vol.46 No.36
Clinical Roundup Opdivo demonstrated superior DFS in resected esophageal or gastroesophageal junction cancer compared to placebo September 25, 2020Vol.46 No.36
Clinical Roundup Opdivo + chemotherapy demonstrated significant OS, PFS benefits versus chemotherapy in gastric and esophageal cancers September 25, 2020Vol.46 No.36
Clinical Roundup Lynparza improved median PFS in BRCA-mutated advanced ovarian cancer September 25, 2020Vol.46 No.36
Clinical Roundup Verzenio significantly reduces risk of cancer recurrence in HR+, HER2- high risk early breast cancer September 25, 2020Vol.46 No.36
Clinical Roundup Padcev significantly improved OS in phase III study of urothelial cancer September 25, 2020Vol.46 No.36
Funding Opportunities Foundation for Giving Life to grant four young scientists up to $270,000 for blood cancer research September 25, 2020Vol.46 No.36
Funding Opportunities Thermo Fisher Scientific to grant up to $200,000 for oncomine clinical research September 25, 2020Vol.46 No.36
